SBIO
Fund Stats as of 04/25/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $33.96
Last Trade Price $33.95
NAV $33.93
NAV Change $-0.03
Total Net Assets $171,331,378
Total Market Value $171,331,858
Premium/Discount(%) 0.09%
Difference ($) $0.03
Volume 23,586
Shares Outstanding 5,050,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Index Characteristics as of 12/31/2017, subject to change

Index Top Ten Holdings

Index Name % of Index
Galapagos Nv-Spon Adr 3.84%
Tesaro Inc 3.64%
Beigene Ltd-Adr 3.59%
Taro Pharmaceutical Ind 3.42%
Akorn Inc 3.25%
Fibrogen Inc 3.14%
Sarepta Therapeutics In 2.90%
Gw Pharmaceuticals -Adr 2.70%
Clovis Oncology Inc 2.69%
Portola Pharmaceutical 2.56%

PMBI Drug Development Pipeline

Pre-Clinical 353
Phase I 348
Phase II 488
Phase III 144
Regulatory Filing for Approval 45
Other 22

Index Profile

Index Description Value
Number of Companies 95
Company Size ($ Millions)
   Average $2,370
   Median $847
   Largest $4,836
   Smallest $169
Weight of Top 10 31.73%
Large cap (>$10bn) 0.0%
Mid cap ($2-10bn) 55.48%
Small cap (<$2bn) 44.52%